OA2-3 BCL-2 antagonism decreases HIV replication and infected cell survival in acute in vitro infection.
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Book |
| Published: |
Elsevier,
2016-07-01T00:00:00Z.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
MARC
| LEADER | 00000 am a22000003u 4500 | ||
|---|---|---|---|
| 001 | doaj_5d39e2d3114d4b14b45b1c9e34eafde5 | ||
| 042 | |a dc | ||
| 100 | 1 | 0 | |a N. Cummins |e author |
| 700 | 1 | 0 | |a A. Sainksi |e author |
| 700 | 1 | 0 | |a S. Natesampillai |e author |
| 700 | 1 | 0 | |a S. Rizza |e author |
| 700 | 1 | 0 | |a S. Kaufmann |e author |
| 700 | 1 | 0 | |a A. Badley |e author |
| 245 | 0 | 0 | |a OA2-3 BCL-2 antagonism decreases HIV replication and infected cell survival in acute in vitro infection. |
| 260 | |b Elsevier, |c 2016-07-01T00:00:00Z. | ||
| 500 | |a 2055-6640 | ||
| 500 | |a 10.1016/S2055-6640(20)31010-4 | ||
| 546 | |a EN | ||
| 690 | |a Microbiology | ||
| 690 | |a QR1-502 | ||
| 690 | |a Public aspects of medicine | ||
| 690 | |a RA1-1270 | ||
| 655 | 7 | |a article |2 local | |
| 786 | 0 | |n Journal of Virus Eradication, Vol 2, Iss , Pp 2-3 (2016) | |
| 787 | 0 | |n http://www.sciencedirect.com/science/article/pii/S2055664020310104 | |
| 787 | 0 | |n https://doaj.org/toc/2055-6640 | |
| 856 | 4 | 1 | |u https://doaj.org/article/5d39e2d3114d4b14b45b1c9e34eafde5 |z Connect to this object online. |